Humana reported Q2 2025 GAAP diluted earnings per share of $4.51 and Adjusted (non-GAAP) EPS of $6.27. For Q2 2024, the figures were $5.62 and $6.96, respectively, and for the 6 months ended 2025, GAAP EPS was $14.81 and Adjusted EPS was $17.85.

1. 01

   Humana reported Q2 2025 GAAP diluted earnings per share of $4.51 and Adjusted (non-GAAP) EPS of $6.27. For Q2 2024, the figures were $5.62 and $6.96, respectively, and for the 6 months ended 2025, GAAP EPS was $14.81 and Adjusted EPS was $17.85.

2. 02

   The company said Q2 2025 Insurance segment benefit ratio was 89.9%, in line with its previously disclosed expectation of approximately 90%. On a GAAP basis for Q2 2024, the ratio was 89.5%.

3. 03

   Humana said it raised FY 2025 Adjusted EPS guidance to approximately $17.00 from approximately $16.25 and adjusted GAAP EPS guidance to approximately $13.77 from approximately $14.68. The company raised consolidated revenue guidance to at least $128 billion from the previous range of $126 billion to $128 billion.

4. 04

   The company said it revised FY 2025 individual Medicare Advantage membership guidance to anticipate a decline of up to 500,000 members from previous guidance of approximately 550,000. It explained that the expected membership decline is inclusive of the impact of exiting certain unprofitable plans and counties.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.